SCHEMBL6596700

SCHEMBL6596700

C=CCn1c(N2CCCN(CCC(CN(C)C(=O)c3cc(OC(F)(F)F)ccc3OC)c3ccc(F)cc3)CC2)nc2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
ALDH1A1 P00352 1/20 0.35
TACR1 P25103 2/20 0.35
HTR3A P46098 1/20 0.34
TACR2 P21452 2/20 0.34
DRD2 P14416 2/20 0.33
DRD4 P21917 2/20 0.33
POLB P06746 1/20 0.33
DRD3 P35462 1/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
CYP2D6 P10635 1/20 0.33
CHRM1 P11229 1/20 0.33
HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6594420 0.94 LMNA (0.35) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL6594416 0.94 LMNA (0.35) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL6594143 0.92 LMNA (0.36) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL6596451 0.91 ALDH1A1 (0.36) LMNAMAPTALDH1A1TACR1
SCHEMBL6596461 0.91 CHRM1 (0.39) LMNAMAPTALDH1A1CHRM1HRH1
SCHEMBL6597910 0.89 MAPT (0.35) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL6595000 0.88 HRH1 (0.37) TACR1TACR2CYP2D6CHRM1HRH1
SCHEMBL6597082 0.86 MEN1 (0.34) MEN1KMT2ALMNAMAPTALDH1A1
SCHEMBL6593835 0.86 TACR2 (0.40) LMNAMAPTALDH1A1TACR1HTR3A
SCHEMBL6597750 0.86 MEN1 (0.35) MEN1KMT2AHTR3ATACR2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888338-B1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES AVENTIS PHARMA INC (US) 2004-11-17 EP disclosed
EP-0888338-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1999-01-07 EP disclosed
WO-1997030991-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1997-08-28 WO disclosed